Fig. 4

Chemical structures of bioactive compounds of Bamboo species (Dendrocalamus hamiltonii, Dendrocalamus longispathus, Bambusa pallida, Bambusa vulgaris, and Bambusa jaintiana) in the Northeast India region. The chemical name and IUPAC names are as follows: Cholesterol-(3S,8S,9S,10R,13R,14S,17R)-10,13-dimethyl-17-[(2R)-6-methylheptan-2-yl]-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-ol); Stigmasterol- (butanedioate;(3S,8S,9S,10R,13R,14S,17R)-17-[(E,2R,5S)-5-ethyl-6-methylhept-3-en-2-yl]-10,13-dimethyl-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-ol); Campesterol- (3S,8S,9S,10R,13R,14S,17R)-17-[(2R,5R)-5,6-dimethylheptan-2-yl]-10,13-dimethyl-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-ol); Stigmastanol-(3S,5S,8R,9S,10S,13R,14S,17R)-17-[(2R,5R)-5-ethyl-6-methylheptan-2-yl]-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-3-ol); Beta-sitosterol- (3S,8S,9S,10R,13R,14S,17R)-17-[(2R,5R)-5-ethyl-6-methylheptan-2-yl]-10,13-dimethyl-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-ol); Ergosterol- (3S,9S,10R,13R,14R,17R)-17-[(E,2R,5R)-5,6-dimethylhept-3-en-2-yl]-10,13-dimethyl-2,3,4,9,11,12,14,15,16,17-decahydro-1H-cyclopenta[a]phenanthren-3-ol); Phenolic acid- (O-hydroxybenzoic acid); Protocatechuic acid- (3,4-dihydroxybenzoic acid); P-hydroxybenzoic acid- (4-Hydroxybenzoic acid); Catechin- (2R,3S)-2-(3,4-dihydroxyphenyl)-3,4-dihydro-2H-chromene-3,5,7-triol); Caffeic acid- (E)-3-(3,4-dihydroxy phenyl) prop-2-enoic acid); Syringic acid- (4-hydroxy-3,5-dimethoxy benzoic acid); Ferulic acid-(E)-3-(4-hydroxy-3-methoxyphenyl)prop-2-enoic acid); Vanillic acid- (4-hydroxy-3-methoxy benzoic acid); Gallic Acid-  (3,4,5-trihydroxy benzoic acid); Chlorogenic acid- (1S,3R,4R,5R)-3-[(E)-3-(3,4-dihydroxyphenyl)prop-2-enoyl]oxy-1,4,5-trihydroxycyclohexane-1-carboxylic acid); Orientin- (2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-8-[(2S,3R,4R,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]chromen-4-one); Iso-orientin- (2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-6-[(2S,3R,4R,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]chromen-4-one); Vitexin- (5,7-dihydroxy-2-(4-hydroxyphenyl)-8-[(2S,3R,4R,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]chromen-4-one); Isovitexin- (5,7-dihydroxy-2-(4-hydroxyphenyl)-6-[(2S,3R,4R,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]chromen-4-one); Tricin-  (5,7-dihydroxy-2-(4-hydroxy-3,5-dimethoxyphenyl)chromen-4-one)